Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950103-19-004878
Filing Date
2019-04-17
Accepted
2019-04-17 16:36:20
Documents
4
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A dp105233_20fa.htm 20-F/A 27286
2 EXHIBIT 4.28 dp105233_ex0428.htm EX-4.28 345239
3 EXHIBIT 12.1 dp105233_ex1201.htm EX-12.1 11457
4 EXHIBIT 12.2 dp105233_ex1202.htm EX-12.2 11323
  Complete submission text file 0000950103-19-004878.txt   396376
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-38556 | Film No.: 19753396
SIC: 2836 Biological Products, (No Diagnostic Substances)